We are live on ! Find out more
TS

Third Security Portfolio holdings

AUM $241M
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
-9.14%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$1.25B
AUM Growth
-$136M
Cap. Flow
-$3.07M
Cap. Flow %
-0.25%
Top 10 Hldgs %
99.33%
Holding
15
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$2.99M
2
FCSC
Fibrocell Science Inc.
FCSC
+$9

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$5.75M
2
TPST icon
Tempest Therapeutics
TPST
+$303K

Sector Composition

Rank Sector Weight
1 Healthcare 93.55%
2 Energy 4.16%
3 Consumer Staples 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGEN icon
1
Precigen
PGEN
$1.79B
$827M 66.4%
59,309,806
+177,101
+0.3% +$2.99M
HALO icon
2
Halozyme
HALO
$9.19B
$292M 23.42%
17,288,450
-304,321
-2% -$5.75M
EPD icon
3
Enterprise Products Partners
EPD
$84B
$31.4M 2.52%
1,135,734
– –
TCRT icon
4
Alaunos Therapeutics
TCRT
$4.93M
$29.3M 2.36%
64,731
– –
AQB icon
5
AquaBounty Technologies
AQB
$4.93M
$25.1M 2.02%
376,915
– –
ET icon
6
Energy Transfer Partners
ET
$70.2B
$14.6M 1.17%
847,650
– –
OCGN icon
7
Ocugen
OCGN
$447M
$6.73M 0.54%
44,843
– –
FCSC
8
DELISTED
Fibrocell Science Inc.
FCSC
$4.47M 0.36%
1,653,486
+3
+0% +$9
ETP
9
DELISTED
Energy Transfer Partners, L.P.
ETP
$3.37M 0.27%
176,828
– –
NS
10
DELISTED
NuStar Energy L.P.
NS
$3.29M 0.26%
145,200
– –
TOVX icon
11
Theriva Biologics
TOVX
$10.6M
$3.16M 0.25%
1,513
– –
TCP
12
DELISTED
TC Pipelines LP
TCP
$2.52M 0.2%
97,000
– –
OGEN icon
13
Oragenics
OGEN
$2.44M
$2.14M 0.17%
860
– –
PRPO icon
14
Precipio
PRPO
$41.8M
$500K 0.04%
4,530
– –
TPST icon
15
Tempest Therapeutics
TPST
$15.3M
– –
-128
Closed -$303K

Similar funds

KRC
Kehrs Ridge Capital Holmdel, New Jersey $260M AUM 0.46% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
FG
Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
UIA
UBP Investment Advisors Geneva, Switzerland $194M AUM 12.96% 1-Year Est. Return
GCM
Gabalex Capital Management New York $181M AUM 9.55% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return

Third Security's Q2 2018 Portfolio in Review

As of Q2 2018, Third Security held 15 positions worth $1.25B, down 9.8% from $1.38B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Third Security's Q2 2018 filing shows 2 increased, 1 reduced and 1 closed positions. The largest sale was Halozyme, an estimated $5.75M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Energy and Consumer Staples.

  • Third Security added most to Precigen in Q2 2018, an estimated $2.99M increase.
  • Third Security's biggest Q2 2018 reduction was Halozyme, cutting an estimated $5.75M.
  • Third Security fully exited Tempest Therapeutics in Q2 2018, selling an estimated $303K.
  • Third Security's ten largest holdings make up 99% of its $1.25B portfolio in Q2 2018.
  • Third Security opened 0 new positions and closed 1 in Q2 2018.
  • Third Security's portfolio value fell 9.8% quarter-over-quarter to $1.25B.

Based on Third Security's 13F filing for Q2 2018, filed 30 Jul 2018.